Your Cart
View all Online Doctor For Schools
Erectile Dysfunction Hair Loss
Shop All View Shop Categories Baby and Child Ear Care Eye Care First Aid Gift Card Haemorrhoids Self Testing Sexual Health Sleep Stop Smoking

Wegovy Tablets

£19.83 /weekly
£105.00
You save £20.00 every order

  • Daily pill instead of weekly injection

  • Average ~17% body weight loss

  • 3 in 10 patients lost 20% or more of starting weight

  • Weight management may be suitable for patients with a BMI of 25 or more*
Subscribe & Save
Auto-renews every 30 days. Cancel anytime.
£105.00
£85.00
  • Free Delivery
  • Clinical Reviews
  • Easy to Manage
  • Track your Savings
Lowest Price Guarantee

  • No needles or storage condition

  • Average 17% body weight loss in phase 3 trials

  • 1 in 4 patients lost 20% or more of starting weight

  • Weight management may be suitable for patients with a BMI of 25 or more

Refer a friend: Both get £40

 

All doses are available to order now.

 

Wegovy tablets are a once-daily weight loss pill containing semaglutide, the same active ingredient used in the Wegovy injection. 

£65.00 £105.00 Subscribe & Save: £85.00 every day
GPhC Registered
Confidential & Discreet
GPhC Registered
Free Delivery (Orders Over £20)
Confidential & Discreet
GPhC Registered
Free Delivery (Orders Over £20)
Confidential & Discreet

Wegovy Tablets Price

At The Family Chemist, we strive to offer affordable private care, regularly checking our prices against competitors to ensure you get the best value for money.

Wegovy Dosage Monthly plan Subscribe & Save Timeline
1.5mg (30 Tablets) £105.00
£85.00/renewal
Weeks 1-4
Starting dose
4mg (30 Tablets) £129.99
£109.99/renewal
Weeks 5-8
Step 2
9mg (30 Tablets) £149.99
£129.99/renewal
Weeks 8-12
Step 3
25mg (30 Tablets) £199.99
£179.99/renewal
Onwards
Maintenance

Save £20 every month

Subscribe & Save on popular treatments

Never miss your next dose. Your treatment can be prepared automatically every month, with a quick check-in before each order.

Subscribe & Save

Best Value

  • Auto-renews every 4 weeks
  • Quick monthly check-in
  • Choose to stay on the same dose, increase, decrease, or pause
  • Cancel anytime
One-time purchase

Best Value

  • Single order only
  • No ongoing savings
  • Reorder manually each month

Your journey
starts here

More than medication. Our pharmacists provide expert support designed to help you succeed. 

“Oral semaglutide is a significant milestone for treating obesity in the UK. Patients will now have access to a clinically proven GLP-1 therapy in tablet form, so people who are put off by injections now have another option”

Dr James Paweleck

Dr James Pawleck  – Medical Director

About Wegovy Tablets

What are Wegovy tablets?

The Wegovy tablet is a once-daily oral alternative to the weekly injection and supports weight loss. Both contain the same active ingredient, semaglutide, but the Wegovy tablet contains an absorption enhancer called SNAC, to protect semaglutide as it passes through the stomach and into your bloodstream.

How does the Wegovy tablet work?

Wegovy mimics GLP-1, a hormone released after eating. It works by:

Reducing appetite: it makes you feel fuller sooner, so you get used to smaller portions and reduce cravings.

Slows digestion: it makes food stay in your stomach for longer, making you feel fuller and less likely to snack between meals

Helps regulate blood sugar: stable blood sugar levels prevent energy crashes and may reduce hunger throughout the day.

Can I buy Wegovy tablets online?

Yes, you can buy Wegovy tablets from The Family Chemist after an free, online assessment that is reviewed and approved by one of our clinicians.

Can I buy the Wegovy tablet over the counter?

No, Wegovy tablets are prescription-only; you will need a prescription from a prescriber after an online assessment to confirm you’re suitable for the medication.

How long do Wegovy tablets take to work?

Some people notice changes in their appetite within the first few weeks, but the starting doses are mainly there to help your body adjust. Weight loss usually becomes more noticable as you move up to higher doses.

The Wegovy tablet follows a 90 day dose escalation schedule, starting at 1.5 mg daily and increasing every 30 days until you reach the 25 mg maintenance dose. This gradual approach helps your body adjust and reduces side effects.

In clinical trials, participants taking 25 mg for 64 weeks saw an average weight loss of 16.6%.

Individual results vary and depend on consistent daily use, following administration instructions, and maintaining healthy lifestyle changes alongside treatment.

Wegovy Tablet dosing schedule

You start on the lowest dose and move up every 30 days. Building up slowly gives your body time to adjust and reduces side effects.

DoseHow to take itWhenNotes
1.5mgOnce dailyDays 1 – 30Starting dose
4mgOnce dailyDays 31 – 60 
9mgOnce dailyDays 61 – 90 
25mgOnce dailyDays 91 onwardsMaximum dose

 

Eligibility

Can I take the Wegovy tablet?

Wegovy tablets are suitable for adults who have:

  • A BMI of 30 or above, or
  • A BMI of 27 or above alongside a weight-related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes

If you’re from a certain background such as South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background, you may be eligible if you have:

  • A BMI of 27 or above, or
  • A BMI of 25 or above alongside a weight-related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes

Who should not take Wegovy tablets?

Wegovy tablets are not suitable for everyone. A qualified clinician will assess whether it is appropriate for you individually.

You should not take Wegovy tablets if you:

  • are pregnant or planning to become pregnant or breastfeeding (stop taking Wegovy tablets at least 2 months before you try to get pregnant)
  • have a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer)
  • have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Are under 18 years of age.(Those aged 85+ will require individual clinical assessment)
  • are allergic to semaglutide or any of the other ingredients in the tablet

You should discuss treatment with a prescriber if you:

  • have a history of pancreatitis
  • have severe kidney or liver disease
  • have diabetic retinopathy (a complication of diabetes affecting the eyes)
  • have severe gastrointestinal disease, including gastroparesis (delayed stomach emptying)
  • are taking other GLP-1 receptor agonist medications, such as Wegovy injections, Ozempic, or Rybelsus
  • are taking insulin or sulfonylureas (such as Gliclazide), as your dose may need lowering to avoid low blood sugar
  • Take levothyroxine for an underactive thyroid, as Wegovy tablets can increase how much levothyroxine you absorb and your thyroid levels may need checking
  • Take other medications every morning, as these must be taken at least 30 minutes after your Wegovy tablet so they do not reduce how much semaglutide you absorb

Results

What results can you expect from the Wegovy tablet?

In the OASIS 4 clinical trial, adults with obesity or who were overweight took the 25 mg Wegovy tablet for 64 weeks.

The results were:

  • Participants lost about 17% of their body weight on average, if they took the medicine throughout the trial
  • About 56% of participants lost 10% or more of their body weight
  • About 30% of participants lost 20% or more of their body weight

These results are similar to those with weekly Wegovy injections. In separate trials users lost an average of 21% of their weight on injections, compared to 17% on the tablet.

The two have not been compared directly however. When including patients who did not complete the 64 week trial, the average weight loss was 13.6% for tablets and 14.9% for injections.

How to take and missed doses

How to take the Wegovy tablet

  • Take 1 Wegovy tablet with a sip of water (no more than 120ml)
  • Only take it on an empty stomach or at least 8 hours after you ate.
  • After 30 minutes, you can eat, drink, or take other medication.
  • Do not split, chew or dissolve Wegovy tablets. 
  • Do not take the tablet with other liquids
  • Do not keep the tablet in any other packaging than the one it came in.

Tip: taking it first thing makes it easier to remember. Find a routine that works best for you.

Wegovy GLP-1 pill infographic showing once-daily oral dosing and key weight-loss benefits.

What if I miss a dose?

If you miss a dose:

  • Skip the missed dose
  • Take your next tablet as normal the following morning
  • Do not take a double dose to make up for a missed one

If you miss multiple doses, contact our clinical team for guidance.

Wegovy tablet comparisons

Wegovy tablet vs Wegovy injection

The tablet and the injection contain the same active ingredient, semaglutide, and produced broadly similar weight loss in separate trials, although they have not been compared directly; the difference is that one is a daily pill and the other is a weekly injection. Results below include all patients who started the trial, even if they did not take the medications for the entire length.

 Wegovy tabletWegovy Injection
Dose25mg daily2.4mg weekly
TrialOASIS 4STEP 1
Average weight loss13.6%14.9%
Trial length64 weeks68 weeks

Wegovy tablet vs Mounjaro

Mounjaro targets both GLP-1 and GIP receptors, which is why it can produce greater weight loss than Wegovy.

 

 Wegovy pillMounjaro
Weight loss13.6% over 64 weeks
(OASIS 4)
20.2% over 72 weeks
(SURMOUNT 5)
DeliveryDaily tabletWeekly injection

Wegovy tablet vs Mounjaro

Mounjaro targets both GLP-1 and GIP receptors, which is why it can produce greater weight loss than Wegovy.

 Wegovy pillFoundayo
Weight loss13.6% over 64 weeks
(OASIS 4)
11.2% over 72 weeks
(ATTAIN-1)
DeliveryDaily tabletDaily tablet

Wegovy tablet side effects

The most common side effects of Wegovy tablets include nausea, vomiting, diarrhoea or constipation, but these usually improve over time.

To reduce side effects, the dose is increased gradually to give your body time to adjust.

Common side effects

  • Dizziness
  • Burping or flatulence
  • Bloating or indigestion
  • Reflux or heartburn
  • Fatigue
  • Hair loss

Less common but serious side effects

Stop taking Wegovy tablets and get medical advice straight away if you have any of these:

  • Pancreatitis – severe stomach pain that spreads to your back and does not go away, with or without vomiting
  • Sudden vision changes (NAION) – sudden, painless loss of vision, usually in one eye
  • Gallstones – pain in the upper right of your tummy, fever, or yellowing of your skin or eyes
  • A lump or swelling in your neck, hoarseness or difficulty swallowing
  • Kidney injury – severe dehydration caused by vomiting and diarrhoea can damage the kidneys
  • Severe allergic reaction – swelling of your face, lips, tongue or throat, or difficulty breathing (call 999)
  • Low blood sugar – shakiness, sweating or confusion, mainly if you also take insulin or a sulfonylurea
  • If you think you are experiencing a side effect, contact our clinical team. You can also report any suspected side effect to the MHRA Yellow Card Scheme

Storage & travel

Storing Wegovy tablets

  • Keep the tablets at room temperature,
  • Store in a dry place. You may not want to keep them in the bathroom if it gets too hot
  • Keep the pills in the original bottle they came in, with the cap tightly closed
  • Wegovy tablets come in a child-resistant bottle. Keep out of reach of children.

Travelling with Wegovy tablets

  • Wegovy tablets can be carried in hand luggage
  • Keep tablets in their original packaging when travelling
  • Avoid leaving tablets in a hot car or in direct sunlight

Switching 

If you are already taking GLP-1 medication, as a tablet or injection, our clinicians will review your current dose, how long you have been on it and how well you have tolerated it. They will then advise when to take your last dose, and what dose to start the Wegovy tablet on. Below are some guides on possible switches, however this remains at the discretion of our clinical team. 

Switching from Mounjaro to Wegovy tablets

Mounjaro injectionWegovy tablet
2.5mg4mg
5mg9mg
7.5mg9mg
10mg25mg
12.5mg25mg
15mg25mg

 

Switching from Wegovy injections to the Wegovy tablet

The tablet and injection are absorbed differently by the body; always make the switch under the guidance of a qualified prescriber.

Wegovy injectionWegovy tablet
0.25mg1.5mg
0.5mg4mg
1mg9mg
7.2mg, 2.4mg or 1.7mg25mg

 

Switching from Wegovy tablet to injection

Wegovy tabletWegovy injection
1.5mg0.25mg
4mg0.5mg
9mg1mg
25mg1.7mg or 2.4mg

 

Switching from Wegovy tablet to Mounjaro

Wegovy tabletMounjaro injection
1.5mg2.5mg
4mg2.5mg
9mg5mg
25mg10mg

FAQs

Do Wegovy tablets affect the contraceptive tablet?

Wegovy does not appear to reduce the effectiveness of hormonal contraception directly. However, side effects such as vomiting or diarrhoea occurring shortly after taking the contraceptive tablet may affect its absorption. Additional contraceptive precautions are recommended if these side effects are present.

Avoid foods that are high in fat, greasy, or very spicy, as well as excessive alcohol and high-sugar drinks. We recommend smaller, more frequent meals and staying hydrated, as this can help reduce side effects and support your weight loss journey.

No. It’s not available on the NHS yet, and there are no confirmed prescribing guidelines.

NICE has not published guidance on Wegovy tablets, and there is currently no confirmed route to getting them on the NHS. Wegovy injections are available through the NHS, but specialist weight management services have waiting lists. Alternatively, you can access the Wegovy tablet by private treatment after completing a short, online consultation.

Clinical Comparison Table

 Wegovy TabletMounjaroMysimbaOrlistat
Active Ingredient(s)SemaglutideTirzepatideNaltrexone & BupropionOrlistat
MechanismGLP-1 receptor agonist. Mimics fullness hormone to reduce appetiteDual GLP-1 and GIP receptor agonist. Targets two hunger hormones simultaneouslyActs on brain regions controlling appetite and cravingsBlocks absorption of approximately one third of dietary fat
AdministrationOnce daily tabletOnce weekly injectionTwice daily tabletUp to three times daily with meals
Average Weight Loss~17%-20% over 71 weeks15% to 22% over 72 weeks~8.1% over 56 weeks~3% to 5% over 12 months
Loss of 20% or more29.7% of patients63% of patients (15mg dose)Not reportedNot reported
Key TrialOASIS 4 (NEJM 2025)SURMOUNT-1 (NEJM 2022)COR programme trialsMultiple RCTs
NHS AvailabilityMHRA approvedYes (NICE approved Dec 2024)No (private only)Yes
Availability in UKNowNowNowNow
 Monthly cost£89.99 to £156.99~£150 – £300~£60 to £80~£30 to £50
Needles neededNoYesNoNo
Suitable forBMI 30+ or BMI 27+ with comorbidityBMI 30+ or BMI 27+ with comorbidityBMI 30+ or BMI 27+ with comorbidityBMI 28+

Cross-trial comparisons should be interpreted with caution due to differences in study populations, trial design, and duration. Sources: OASIS 4 (Wharton et al, NEJM 2025), SURMOUNT-1 (Jastreboff et al, NEJM 2022), COR programme trials, NICE TA875/TA664.

Sources

Semaglutide(2024)National Library of Medicine [accessed 30th October 2026]

Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes (1998)National Library of Medicine [accessed 30th October 2026]

Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management (2000) Diabetes Care [accessed 30th October 2026]

Once-Weekly Semaglutide in Adults with Overweight or Obesity(2021)The New England Journal of Medicine [accessed 30th October 2026]

Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist (2018) Science Translational Medicine [accessed 30th October 2026]

Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (2025) The New England Journal of Medicine [accessed 30th October 2026]

Wegovy® (semaglutide) Tablet: Your Complete Guide to Wegovy Tablet (2026) Novo Nordisk [accessed 30th October 2026

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (2025) The New England Journal of Medicine [accessed 30th October 2026]

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment (2025) The New England Journal of Medicine [accessed 30th October 2026]

Wegovy 25 mg tablets – Summary of Product Characteristics: Undesirable Effects (2026) emc [accessed 30th October 2026]

Wegovy 25 mg tablets – Summary of Product Characteristics: Contraindications (2026) emc [accessed 30th October 2026]

Wegovy 25 mg tablets – Summary of Product Characteristics: Posology and Method of Administration (2026) emc [accessed 30th October 2026]

First GLP-1 tablet for weight loss approved in the UK (2026) Medicines and Healthcare products Regulatory Agency [accessed 30th October 2026]

Medically
reviewed by

Dr James Paweleck

Role: Medical Director

GMC Number: 7332635

Reviewed: 12h November 2026

Dr James Paweleck

Last reviewed: 12th November 2026

Meet our
medical professionals

Sunny Dhain

Clinical Director

GPhC: 2073665

Kamaldeep Kaur

Pharmacist Prescriber

GPhC: 2223636

Aaliyah Nelson

Nutritional Coaching

BSc (Hons) Nutrition: 47988

Standards first
always

Subscribe & Save £20 every month

Start your weight loss journey with personalised treatment and support
Am I eligible?